Literature DB >> 25728541

Vestibular migraine.

Joseph M Furman1, Carey D Balaban.   

Abstract

Vestibular migraine is now considered a distinct diagnostic entity by both the Barany Society and the International Headache Society. The recognition of vestibular migraine as a diagnostic entity required decades and was presaged by several reports indicating that a large proportion of patients with migraine headaches have vestibular symptoms and that a large proportion of patients with undiagnosed episodic vestibular symptoms have migraine headache. Despite the availability of diagnostic criteria for vestibular migraine, challenges to diagnosis include variability in terms of the character of dizziness, the presence or absence of clearly defined attacks, the duration of attacks, and the temporal association between headache or other migrainous features and vestibular symptoms. Also, symptoms of vestibular migraine often overlap with symptoms of other causes of dizziness, especially Ménière's disease and benign paroxysmal positional vertigo (BPPV). This article will discuss the demographics, epidemiology, clinical manifestations, physical examination findings, laboratory testing, comorbidities, treatment options, and pathophysiology of vestibular migraine. Future research in the field of vestibular migraine should include both clinical and basic science efforts to better understand the pathophysiology of this condition. Controlled treatment trials for vestibular migraine are desperately needed.
© 2015 New York Academy of Sciences.

Entities:  

Keywords:  dizziness; headache; imbalance; migraine; vertigo; vestibular

Mesh:

Year:  2015        PMID: 25728541     DOI: 10.1111/nyas.12645

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

1.  Development of a Statistical Model for the Prediction of Common Vestibular Diagnoses.

Authors:  David R Friedland; Sergey Tarima; Christy Erbe; Alexia Miles
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-04       Impact factor: 6.223

Review 2.  Vestibular Migraine in Children and Adolescents.

Authors:  Thyra Langhagen; Mirjam N Landgraf; Doreen Huppert; Florian Heinen; Klaus Jahn
Journal:  Curr Pain Headache Rep       Date:  2016-12

Review 3.  Vestibular migraine: who is the patient?

Authors:  Bruno Colombo; Roberto Teggi
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

4.  Outcome of vestibular rehabilitation in vestibular migraine.

Authors:  Birgul Balci; Gülden Akdal
Journal:  J Neurol       Date:  2022-07-08       Impact factor: 4.849

5.  Comparison of Electrocochleography and Video Head Impulse Test findings in Vestibular Migraine and Ménière Disease: A Preliminary Study.

Authors:  Francesco Martines; Francesco Dispenza; Calogero Montalbano; Roberta Priola; Angelo Torrente; Rosario La Gumina; Filippo Brighina; Francesco Galletti; Pietro Salvago
Journal:  J Int Adv Otol       Date:  2020-08       Impact factor: 1.017

Review 6.  Vertigo and Dizziness in the Elderly.

Authors:  Lara Fernández; Hayo A Breinbauer; Paul Hinckley Delano
Journal:  Front Neurol       Date:  2015-06-26       Impact factor: 4.003

Review 7.  Vestibular migraine: the most frequent entity of episodic vertigo.

Authors:  Marianne Dieterich; Mark Obermann; Nese Celebisoy
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

8.  Vestibular Function Tests for Vestibular Migraine: Clinical Implication of Video Head Impulse and Caloric Tests.

Authors:  Woo Seok Kang; Sang Hun Lee; Chan Joo Yang; Joong Ho Ahn; Jong Woo Chung; Hong Ju Park
Journal:  Front Neurol       Date:  2016-09-30       Impact factor: 4.003

Review 9.  Vestibular Migraine: Clinical Challenges and Opportunities for Multidisciplinarity.

Authors:  Isabel Luzeiro; Leonel Luís; Freire Gonçalves; Isabel Pavão Martins
Journal:  Behav Neurol       Date:  2016-12-19       Impact factor: 3.342

Review 10.  Recent Advances in the Understanding of Vestibular Migraine.

Authors:  Jong-Hee Sohn
Journal:  Behav Neurol       Date:  2016-10-16       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.